Notice of Investigation – Distal Biceps Brachii Tendinopathy

Overview

The Repatriation Medical Authority (RMA), under section 196G of the Veterans' Entitlements Act 1986, has issued a notice of investigation into distal biceps brachii tendinopathy. This initiative is aimed at addressing a specific medical condition affecting veterans and ensuring that their health claims are thoroughly assessed. The RMA is inviting submissions from eligible claimants, representatives of veterans' organisations, and experts with relevant expertise to provide their insights and evidence in relation to the investigation. The first meeting for this investigation is scheduled for 6 August 2024, and all written submissions must be received by the Authority no later than 26 July 2024. This legislative action by the RMA aims to fill a gap in the comprehensive evaluation and recognition of distal biceps brachii tendinopathy as a condition related to military service.

Scope and Application

The Repatriation Medical Authority (the Authority) under section 196G of the Veterans' Entitlements Act 1986 has announced its intention to conduct an investigation into distal biceps brachii tendinopathy as per subsections 196B(4) of the VEA. This investigation is open to submissions from various stakeholders, including individuals eligible to claim pension or compensation under the VEA or the Military Rehabilitation and Compensation Act 2004, organisations representing veterans or their dependants, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts in relevant fields. The Authority's first meeting for this investigation is scheduled for 6 August 2024. Submissions can be made electronically via the RMA website, by email, or by post, and must be received by 26 July 2024. The investigation is a Commonwealth matter, applying to relevant entities and individuals within Australia. There are no stated exclusions, exemptions, or thresholds in this notice, and the scope of the investigation may be further defined through subordinate instruments.

Key Provisions

The primary sections of the notice pertain to the investigation of distal biceps brachii tendinopathy as outlined under section 196G of the Veterans' Entitlements Act 1986 (VEA). This section informs the public that the Repatriation Medical Authority (the Authority) has initiated an investigation into the specified medical condition, and it specifies the timeline and process for this investigation. It also invites various stakeholders to contribute by making written submissions. These stakeholders include individuals eligible to make claims under the VEA or the Military Rehabilitation and Compensation Act 2004 (MRCA), organisations representing veterans and related groups, and experts in relevant fields. Submissions can be made electronically via the RMA website, by email, or by post, and must be received by 26 July 2024. The first meeting of the investigation is scheduled for 6 August 2024. The obligations imposed by this notice are primarily on the invited parties, requiring them to submit written contributions by the specified deadline. Eligible individuals and organisations must ensure that their submissions are made in accordance with the guidelines provided by the RMA. This includes submitting their views and any relevant information that could assist the Authority in its investigation. The notice also serves as an invitation to these parties to participate in the investigation, thereby ensuring that the process is inclusive and informed by a variety of perspectives. Failure to comply with the submission requirements outlined in the notice may result in the exclusion of relevant information that could impact the investigation's findings and subsequent decisions. There are no explicit penalties mentioned in the notice for not submitting a contribution, but the omission of valuable insights could potentially affect the comprehensiveness of the investigation. Additionally, any misrepresentation or submission of false information could lead to further scrutiny or consequences under relevant legislation. The notice does not explicitly outline criminal or civil penalties for non-compliance with the submission process. However, the importance of adhering to the specified guidelines and deadlines is implicitly underscored. Given that the investigation concerns a medical condition affecting veterans, the outcomes of this investigation could have significant implications for those affected, potentially influencing their entitlements and benefits under the VEA or MRCA. Therefore, the integrity and accuracy of the submissions are crucial.